Company
United StatesPublic company, NASDAQ: LUCDLucid Diagnostics, Inc. (NASDAQ: LUCD), Foxboro, MA – FDA Inspections
Inspection records and compliance data for Lucid Diagnostics, Inc. in Foxboro, Massachusetts. 1 FDA inspection on record, last inspected March 21, 2022. Publicly traded as NASDAQ: LUCD.
Company Profile
This profile covers Lucid Diagnostics, Inc. based in Foxboro, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected March 21, 2022.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 21, 2022 | VAI | Medical Devices & Rad Health · Compliance: Devices | 1164972 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Lucid Diagnostics, Inc.
Stock ticker
LUCD
Exchange
NASDAQ
Share price
$0.42
Market cap
$86.2M
Price as of
November 13, 2026
FEI Number
3016490370
Address
200 Foxborough Blvd Ste 300, Foxboro, Massachusetts 02035, United States
Country
United States
ID: a55b122d-6600-4f86-a40a-a25bd83e7d14